About GD
GD is a company based in Mumbai (India) founded in 2007 by Susheel Kumar Singh. GD has raised $11.5 million across 3 funding rounds from investors including Alka Diamond Industries, InvAscent and Kush Hindustan Entertainment. The company has 365 employees as of April 04, 2024. GD offers products and services including Diagnostic Tests, Collection Centers, and Laboratory Services. GD operates in a competitive market with competitors including Thyrocare, Vijaya Diagnostic Centre, Suraksha Diagnostics, Krsnaa Diagnostics and Igenetic, among others.
- Headquarter Mumbai, India
- Employees 365 as on 04 Apr, 2024
- Founders Susheel Kumar Singh
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name General Diagnostics International Private Limited
- Date of Incorporation 03 Apr, 2007
-
Annual Revenue
$4.88 M (USD)-33.38as on Mar 31, 2023
-
Net Profit
-$569.25 K (USD)-215.22as on Mar 31, 2023
-
EBITDA
$40.87 K (USD)-96.31as on Mar 31, 2023
-
Total Equity Funding
$11.5 M (USD)
in 3 rounds
-
Latest Funding Round
$10.5 M (USD), Series A
May 25, 2023
-
Investors
Alka Diamond Industries
& 8 more
-
Employee Count
365
as on Apr 04, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GD
GD offers a comprehensive portfolio of products and services, including Diagnostic Tests, Collection Centers, and Laboratory Services.
Performs over 1,500 diagnostic tests for patients and hospitals.
Manages sample collection at partnered centers across India.
Provides quality-controlled lab processing for medical samples.
People of GD
Unlock access to complete
Funding Insights of GD
GD has successfully raised a total of $11.5M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10.5 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $10.5M
-
First Round
First Round
(31 Mar 2008)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Series A - GD | Valuation |
investors |
|
| Sep, 2009 | Amount | Seed - GD | Valuation | Alka Diamond Industries | |
| Mar, 2008 | Amount | Seed - GD | Valuation | Shabana Altaf |
Investors in GD
GD has secured backing from 9 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Alka Diamond Industries, InvAscent and Kush Hindustan Entertainment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life sciences investments in India.
|
Founded Year | Domain | Location | |
|
Venture capital investments are directed toward multiple sectors.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location |
Investments & Acquisitions by GD
Financial Statements - GD
Gd Comparisons
Competitors of GD
GD operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Thyrocare, Vijaya Diagnostic Centre, Suraksha Diagnostics, Krsnaa Diagnostics and Igenetic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic testing centers for pathology and health screenings are operated.
|
|
| domain | founded_year | HQ Location |
Diagnostic services are offered via a chain of centers.
|
|
| domain | founded_year | HQ Location |
Pathology, molecular diagnostics, and imaging services are provided.
|
|
| domain | founded_year | HQ Location |
Chain of radiology & pathology laboratory centers
|
|
| domain | founded_year | HQ Location |
Provider molecular diagnostic solutions and services
|
|
| domain | founded_year | HQ Location |
Medical diagnostic services are provided through a chain of centres.
|
Frequently Asked Questions about GD
GD was founded in 2007 and raised its 1st funding round 1 year after it was founded.
GD is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Abhimanyu Kumar is the current CEO of GD.
GD is a funded company, having raised a total of $11.5M across 3 funding rounds to date. The company's 1st funding round was a Seed of $501.25K, raised on Mar 31, 2008.
As of Apr 04, 2024, the latest employee count at GD is 365.
Annual revenue of GD is $4.88M as on Mar 31, 2023.
GD was founded in 2007 in Mumbai, India, and functions within the healthcare sector as a chain of clinical laboratories. Diagnostic testing and related medical services are provided across multiple facilities. Operations are centered in India, with leadership including Co-Founder Susheel Kumar Singh and CEO Abhimanyu Kumar. The company maintains a domain at gd-lab.com for its activities.
GD's top competitors include Thyrocare, Krsnaa Diagnostics and Suraksha Diagnostics.
GD offers Diagnostic Tests, Collection Centers, and Laboratory Services.
GD has 9 investors. Key investors include Alka Diamond Industries, InvAscent, Kush Hindustan Entertainment, Javda India Impex, and Triangular Infocom Limited.
The valuation of GD is $27.27M as of May 2023.